SS
ANIK icon

Sunbelt Securities’s Anika Therapeutics ANIK Stock Holding History

Sunbelt Securities’s Portfolio ANIK Stock Details ANIK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$261 Buy
18
+8
+80% +$93 ﹤0.01% 2452
2025
Q4 		$96 Buy
+10
New +$96 ﹤0.01% 2554

Other funds holding ANIK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CP
Caligan Partners New York $1.5B AUM 518.95% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
CM
Capital Management Glen Allen, Virginia $585M AUM 5.18% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Sunbelt Securities's ANIK Position: Q1 2026 in Review

Sunbelt Securities increased its Anika Therapeutics (ANIK) stake by 80% in Q1 2026, buying an estimated $93 and bringing the position to 18 shares worth $261. The position accounts for ﹤0.01% of the portfolio, ranked #2452.

Sunbelt Securities first reported a position in ANIK in Q4 2025 and has held it in 2 quarters since. 130 funds tracked by Wall St. Rank hold ANIK as of Q1 2026.

  • Sunbelt Securities held 18 shares of Anika Therapeutics worth $261 as of Q1 2026.
  • Sunbelt Securities bought 8 Anika Therapeutics shares in Q1 2026, an estimated $93.
  • Anika Therapeutics made up ﹤0.01% of Sunbelt Securities's portfolio in Q1 2026, its #2452 holding.
  • Sunbelt Securities first reported a position in Anika Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • 130 funds tracked by Wall St. Rank held Anika Therapeutics as of Q1 2026.

Based on Sunbelt Securities's 13F filing for Q1 2026, filed 18 May 2026.